Ichor Medical Systems

Bronze Sponsor

Ichor is dedicated to the clinical application and commercialization of its TriGrid™ electroporation technology for the delivery of nucleic acid based biologics to treat a broad spectrum of disease indications including cancer, chronic viral infections, HIV, ebola and multiple biodefense agents.  Ichor has established several ongoing research and development collaborations and licensing agreements to advance the development of its TriGrid system with partners such as Pfizer, Janssen, Scancell, Genexine, NIH, US Department of Defense, ADARC, Washington University, IAVI and others.  Ichor continues to seek strategic partnerships to provide our enabling technology to collaborators interested in expanding their product pipeline in a number of disease indications.